Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Immunitybio Inc (IBRX)

Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Biotech Companies’ Q3 Updates: Promising Cancer Treatments on the Horizon BayStreet.ca - Thu Nov 14, 8:45AM CST

USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As many biotech companies within the oncology space begin to roll...

ONCY : 0.9864 (-1.21%)
IOVA : 8.32 (+2.21%)
SNDX : 16.06 (+0.69%)
ONC.TO : 1.38 (-1.43%)
IBRX : 5.02 (+2.87%)
SWTX : 37.16 (-0.75%)
Biotech Companies' Q3 Updates: Promising Cancer Treatments on the Horizon Newswire.ca - Thu Nov 14, 7:00AM CST

/CNW/ -- USA News Group News Commentary – As many biotech companies within the oncology space begin to roll out their end-of-quarter results, the American...

ONCY : 0.9864 (-1.21%)
IOVA : 8.32 (+2.21%)
SNDX : 16.06 (+0.69%)
ONC.TO : 1.38 (-1.43%)
IBRX : 5.02 (+2.87%)
SWTX : 37.16 (-0.75%)
ImmunityBio: Q3 Earnings Snapshot AP - Tue Nov 12, 6:36AM CST

ImmunityBio: Q3 Earnings Snapshot

IBRX : 5.02 (+2.87%)
Analysts Predict Strong Growth for Cancer Vaccine Market: Key Biotech Stocks to Consider BayStreet.ca - Wed Sep 4, 11:39AM CDT

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Back in 2022, Nature published...

BIOV.CN : 0.0700 (+7.69%)
BVAXF : 0.0510 (+1.19%)
BNTX : 104.07 (+1.89%)
CVAC : 2.53 (+1.61%)
VXRT : 0.6034 (-0.72%)
IBRX : 5.02 (+2.87%)
ImmunityBio: Q2 Earnings Snapshot AP - Mon Aug 12, 7:11AM CDT

ImmunityBio: Q2 Earnings Snapshot

IBRX : 5.02 (+2.87%)
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 Newswire.ca - Wed May 1, 9:05AM CDT

/CNW/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of...

BIOV.CN : 0.0700 (+7.69%)
BVAXF : 0.0510 (+1.19%)
MRNA : 36.96 (+0.05%)
BOLD : 2.64 (-2.58%)
IBRX : 5.02 (+2.87%)
MGNX : 3.27 (-0.30%)
Promising Outlook as Biotech Sector Advances Cancer Treatments Amidst Rising Diagnoses BayStreet.ca - Wed May 1, 8:54AM CDT

USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of cancer. A new report from the American Cancer Society...

BRX : 29.74 (+0.37%)
BIOV.CN : 0.0700 (+7.69%)
BVAXF : 0.0510 (+1.19%)
MRNA : 36.96 (+0.05%)
BOLD : 2.64 (-2.58%)
IBRX : 5.02 (+2.87%)
MGNX : 3.27 (-0.30%)
Biotech Sector Advances in Pancreatic Cancer Research BayStreet.ca - Thu Mar 14, 8:42AM CDT

USA News Group – Known as one of the most deadly forms of cancer, pancreatic cancer still has the highest mortality rate of all major cancers today. However, researchers and the biotech sector are working...

BRX : 29.74 (+0.37%)
ONCY : 0.9864 (-1.21%)
ONC.TO : 1.38 (-1.43%)
NVS : 103.32 (+0.22%)
IBRX : 5.02 (+2.87%)
ACRS : 4.22 (+6.57%)
NUVB : 2.66 (+3.10%)
Biotech’s Role in Addressing the Pancreatic Cancer Emergency FinancialNewsMedia - Thu Mar 14, 7:45AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END

NVX : 1.9300 (-2.03%)
ONCY : 0.9864 (-1.21%)
ONC.TO : 1.38 (-1.43%)
NVS : 103.32 (+0.22%)
IBRX : 5.02 (+2.87%)
ACRS : 4.22 (+6.57%)
NUVB : 2.66 (+3.10%)
Should You Still Buy the Nasdaq's Best-Performing October Stocks? Motley Fool - Fri Nov 3, 2023

Last month's big winners were tricky to handle due to the amount of speculation investors were willing to do with them.

COMP : 6.57 (+2.02%)
GPCR : 31.36 (-4.13%)
IBRX : 5.02 (+2.87%)
OLK : 26.08 (+0.31%)

Barchart Exclusives

1 EV Stock Under $10 With 25% Upside Potential Barchart - 58 minutes ago
This charging stock has been under heavy pressure lately amid concerns over the fate of EV tax credits. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot